Join to View Full Profile
Hillcrest HospitalAtrium suite 226Cleveland, OH 44123
Dr. Altman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Andrew Altman is a urology specialist based in Cleveland, OH. He completed his medical degree at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in 1995 and finished his urology residency in 2001 at Case Western Reserve University/University Hospitals Cleveland Medical Center. Dr. Altman has contributed to several publications in the field, with notable works including studies on post-vasectomy semen analysis, long-term toxicity after prostate cancer treatments, PSA bounce, biochemical failure after brachytherapy, and the significance of PSA testing frequency. His research has been cited numerous times, reflecting engagement with the wider medical community in his specialty.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Urology, 2001
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1995
Certifications & Licensure
OH State Medical License 1996 - 2027
American Board of Urology Urology
Publications & Presentations
PubMed
- 9 citationsPost-Vasectomy Semen Analysis: Optimizing Laboratory Procedures and Test Interpretation through a Clinical Audit and Global Survey of Practices.Ashok Agarwal, Sajal Gupta, Rakesh K Sharma, Renata Finelli, Shinnosuke Kuroda
The World Journal of Men's Health. 2022-07-01 - 31 citationsLong-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate c...G.K. Hunter, Chandana A. Reddy, Eric A. Klein, Patrick A. Kupelian, Kenneth W. Angermeier
Prostate Cancer. 2012-04-11 - 53 citationsPSA bounce and biochemical failure after brachytherapy for prostate cancer: a study of 820 patients with a minimum of 3 years of follow-up.Murat Caloglu, Jay P. Ciezki, Chandana A. Reddy, Kenneth W. Angermeier, James Ulchaker
International Journal of Radiation Oncology, Biology, Physics. 2011-07-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
